Site-directed structure generation by fragment-joining

被引:25
作者
Bohm, HJ
机构
[1] BASF AG, Main Laboratory, Carl-Bosch Strasse, Ludwigshafen
关键词
D O I
10.1007/BF02174465
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Recently, several computer programs for de novo ligand design have been described that construct novel molecules by combining several fragments into one molecule. The present review discusses the advantages and disadvantages of this fragment-based approach to de novo design. The computer program LUDI for automated structure-based ligand design is described in some detail. This program constructs possible new ligands for a given protein of known three-dimensional structure. In addition, LUDI can also be used for 3D database searching. LUDI is based upon rules about energetically favorable nonbonded contact geometries between functional groups of the protein and the ligand which are derived from a statistical analysis of crystal packings of organic molecules. All putative ligands retrieved or constructed by LUDI are scored by a simple scoring function that was fitted to experimentally determined binding constants of protein-ligand complexes. LUDI is a fast program that is suitable for interactive usage.
引用
收藏
页码:21 / 33
页数:13
相关论文
共 62 条
  • [31] RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS
    LAM, PYS
    JADHAV, PK
    EYERMANN, CJ
    HODGE, CN
    RU, Y
    BACHELER, LT
    MEEK, JL
    OTTO, MJ
    RAYNER, MM
    WONG, YN
    CHANG, CH
    WEBER, PC
    JACKSON, DA
    SHARPE, TR
    ERICKSONVIITANEN, S
    [J]. SCIENCE, 1994, 263 (5145) : 380 - 384
  • [32] AUTOMATED SITE-DIRECTED DRUG DESIGN USING MOLECULAR LATTICES
    LEWIS, RA
    ROE, DC
    HUANG, C
    FERRIN, TE
    LANGRIDGE, R
    KUNTZ, ID
    [J]. JOURNAL OF MOLECULAR GRAPHICS, 1992, 10 (02): : 66 - 78
  • [33] AUTOMATED SITE-DIRECTED DRUG DESIGN - THE FORMATION OF MOLECULAR TEMPLATES IN PRIMARY STRUCTURE GENERATION
    LEWIS, RA
    DEAN, PM
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1989, 236 (1283): : 141 - +
  • [34] AUTOMATED SITE-DIRECTED DRUG DESIGN - THE CONCEPT OF SPACER SKELETONS FOR PRIMARY STRUCTURE GENERATION
    LEWIS, RA
    DEAN, PM
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1989, 236 (1283): : 125 - 140
  • [35] DESIGN, SYNTHESIS AND BIOLOGICAL-ACTIVITY OF NOVEL RIGID AMIDINO-PHENYLALANINE DERIVATIVES AS INHIBITORS OF THROMBIN
    MACK, H
    PFEIFFER, T
    HORNBERGER, W
    BOHM, HJ
    HOFFKEN, HW
    [J]. JOURNAL OF ENZYME INHIBITION, 1995, 9 (01): : 73 - &
  • [36] MARESGUIA M, 1965, J BIOL CHEM, V240, P1579
  • [37] THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS
    MARQUART, M
    WALTER, J
    DEISENHOFER, J
    BODE, W
    HUBER, R
    [J]. ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1983, 39 (AUG): : 480 - 490
  • [38] 3D DATABASE SEARCHING IN DRUG DESIGN
    MARTIN, YC
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (12) : 2145 - 2154
  • [39] STRUCTURE OF COMPLEX OF SYNTHETIC HIV-1 PROTEASE WITH A SUBSTRATE-BASED INHIBITOR AT 2.3-A RESOLUTION
    MILLER, M
    SCHNEIDER, J
    SATHYANARAYANA, BK
    TOTH, MV
    MARSHALL, GR
    CLAWSON, L
    SELK, L
    KENT, SBH
    WLODAWER, A
    [J]. SCIENCE, 1989, 246 (4934) : 1149 - 1152
  • [40] FUNCTIONALITY MAPS OF BINDING-SITES - A MULTIPLE COPY SIMULTANEOUS SEARCH METHOD
    MIRANKER, A
    KARPLUS, M
    [J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1991, 11 (01): : 29 - 34